Fifth Third Wealth Advisors LLC Buys 716 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Fifth Third Wealth Advisors LLC lifted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 80.4% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,607 shares of the company's stock after acquiring an additional 716 shares during the quarter. Fifth Third Wealth Advisors LLC's holdings in HCA Healthcare were worth $555,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in the company. Congress Wealth Management LLC DE boosted its stake in shares of HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after buying an additional 34 shares during the period. Evergreen Private Wealth LLC lifted its stake in HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after acquiring an additional 35 shares during the last quarter. Prairie Wealth Advisors Inc. raised its holdings in shares of HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after purchasing an additional 40 shares in the last quarter. Whittier Trust Co. increased its position in HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after buying an additional 41 shares during the last quarter. Finally, Coldstream Capital Management Inc. increased its holdings in shares of HCA Healthcare by 1.3% during the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock valued at $1,042,000 after acquiring an additional 44 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

HCA has been the subject of several research analyst reports. Barclays boosted their price objective on HCA Healthcare from $366.00 to $416.00 and gave the stock an "overweight" rating in a research report on Monday. Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their price objective for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Royal Bank of Canada cut their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Robert W. Baird restated a "neutral" rating and set a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Finally, Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Seven equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $388.80.

HCA Healthcare Stock Performance

NYSE HCA traded down $0.31 during trading on Thursday, reaching $381.35. The company's stock had a trading volume of 1,058,650 shares, compared to its average volume of 1,438,757. The firm has a market capitalization of $91.74 billion, a price-to-earnings ratio of 17.36, a price-to-earnings-growth ratio of 1.10 and a beta of 1.46. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm has a 50 day moving average price of $353.80 and a 200 day moving average price of $331.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same quarter last year, the business posted $5.36 EPS. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio is 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.